Scrip“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office
ScripApellis Pharmaceuticals, Inc. ’s Syfovre is taking the heat following the publication of a letter recommending doctors exercise caution after a few instances of a previously unseen safety event emerge